Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled study

OPTIC-IBD Study Grp; M. Iacucci; S. Ghosh

Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled study

OPTIC-IBD Study Grp
, M. Iacucci
, S. Ghosh

School of Medicine

Research output: Contribution to journal › Meeting abstract › peer-review

Abstract

Inflammatory bowel disease (IBD) increases colorectal cancer risk. To mitigate this patients undergo endoscopic surveillance to detect dysplasia. However, chronic inflammation alters mucosal and vascular colonic architecture, complicating lesion recognition. Endoscopic advances enhance our ability to accurately characterise these lesions. But training on optical diagnosis of dysplastic lesions in IBD is not widely available. We aim to fill this gap by developing and validating the new OPTIC-IBD online training platform (Figure 1, NCT04924543, funding GutsUK TRN2019-03).

Original language	English
Pages (from-to)	I063-I064
Number of pages	3
Journal	Journal of Crohn's and Colitis
Volume	16
Publication status	Published - 21 Jan 2022
Event	17th Congress of European Crohn's and Colitis Organisation (ECCO) 2022 - Virtual Duration: 16 Feb 2022 → 19 Feb 2022

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Cite this

@article{45fd9d2dc344498fb96c2941b9892ef6,

title = "Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled study",

abstract = "Inflammatory bowel disease (IBD) increases colorectal cancer risk. To mitigate this patients undergo endoscopic surveillance to detect dysplasia. However, chronic inflammation alters mucosal and vascular colonic architecture, complicating lesion recognition. Endoscopic advances enhance our ability to accurately characterise these lesions. But training on optical diagnosis of dysplastic lesions in IBD is not widely available. We aim to fill this gap by developing and validating the new OPTIC-IBD online training platform (Figure 1, NCT04924543, funding GutsUK TRN2019-03).",

author = "\{OPTIC-IBD Study Grp\} and M. Iacucci and Smith, \{S. C. L.\} and S. Ghosh",

year = "2022",

month = jan,

day = "21",

language = "English",

volume = "16",

pages = "I063--I064",

journal = "Journal of Crohn's and Colitis",

issn = "1873-9946",

publisher = "Oxford University Press",

note = "17th Congress of European Crohn's and Colitis Organisation (ECCO) 2022 ; Conference date: 16-02-2022 Through 19-02-2022",

}

Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled study. / OPTIC-IBD Study Grp ; Iacucci, M.; Ghosh, S.
In: Journal of Crohn's and Colitis, Vol. 16, 21.01.2022, p. I063-I064.

Research output: Contribution to journal › Meeting abstract › peer-review

TY - JOUR

T1 - Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD)

T2 - 17th Congress of European Crohn's and Colitis Organisation (ECCO) 2022

AU - OPTIC-IBD Study Grp

AU - Iacucci, M.

AU - Smith, S. C. L.

AU - Ghosh, S.

PY - 2022/1/21

Y1 - 2022/1/21

N2 - Inflammatory bowel disease (IBD) increases colorectal cancer risk. To mitigate this patients undergo endoscopic surveillance to detect dysplasia. However, chronic inflammation alters mucosal and vascular colonic architecture, complicating lesion recognition. Endoscopic advances enhance our ability to accurately characterise these lesions. But training on optical diagnosis of dysplastic lesions in IBD is not widely available. We aim to fill this gap by developing and validating the new OPTIC-IBD online training platform (Figure 1, NCT04924543, funding GutsUK TRN2019-03).

AB - Inflammatory bowel disease (IBD) increases colorectal cancer risk. To mitigate this patients undergo endoscopic surveillance to detect dysplasia. However, chronic inflammation alters mucosal and vascular colonic architecture, complicating lesion recognition. Endoscopic advances enhance our ability to accurately characterise these lesions. But training on optical diagnosis of dysplastic lesions in IBD is not widely available. We aim to fill this gap by developing and validating the new OPTIC-IBD online training platform (Figure 1, NCT04924543, funding GutsUK TRN2019-03).

UR - https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=pureucc&SrcAuth=WosAPI&KeyUT=WOS:000778573400055&DestLinkType=FullRecord&DestApp=WOS_CPL

M3 - Meeting abstract

SN - 1873-9946

VL - 16

SP - I063-I064

JO - Journal of Crohn's and Colitis

JF - Journal of Crohn's and Colitis

Y2 - 16 February 2022 through 19 February 2022

ER -

Validation of a new OPtical diagnosis Training platform to Improve dysplasia Characterisation in Inflammatory Bowel Disease (OPTIC-IBD): A multicentre randomised controlled study

Abstract

UN SDGs

Other files and links

Fingerprint

Cite this